TAMSU P.R TEVA Израел - английски - Ministry of Health

tamsu p.r teva

abic marketing ltd, israel - tamsulosin hydrochloride - tablets prolonged release - tamsulosin hydrochloride 0.4 mg - tamsulosin - lower urinary tract symptoms ( luts) associated with benign prostatic hyperplasia (bph).

BOSENTAN TEVA  125 MG Израел - английски - Ministry of Health

bosentan teva 125 mg

abic marketing ltd, israel - bosentan as monohydrate - film coated tablets - bosentan as monohydrate 125 mg - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease.

BOSENTAN TEVA  62.5 MG Израел - английски - Ministry of Health

bosentan teva 62.5 mg

abic marketing ltd, israel - bosentan as monohydrate - film coated tablets - bosentan as monohydrate 62.5 mg - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease.

DUORESP  SPIROMAX  160 MCG4.5 MCG Израел - английски - Ministry of Health

duoresp spiromax 160 mcg4.5 mcg

abic marketing ltd, israel - budesonide micronized; formoterol fumarate dihydrate - powder for inhalation - formoterol fumarate dihydrate 4.5 mcg/dose; budesonide micronized 160 mcg/dose - formoterol and budesonide - asthmaduoresp spiromax 160/4.5 mcg/dose is indicated in adults and adolescents (12 years and older), for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long acting β2 adrenoceptor agonist) is appropriate:patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short acting β2 adrenoceptor agonists.orpatients already adequately controlled on both inhaled corticosteroids and long acting β2 adrenoceptor-agonists.chronic obstructive pulmonary disease (copd)duoresp spiromax 160/4.5 mcg/dose is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev1)< 70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy

AVCAMOL 250 MG Израел - английски - Ministry of Health

avcamol 250 mg

abic marketing ltd, israel - paracetamol - granules - paracetamol 250 mg/stick pack - paracetamol - paracetamol - analgesic, antipyretic .

AVCAMOL 500 MG Израел - английски - Ministry of Health

avcamol 500 mg

abic marketing ltd, israel - paracetamol - granules - paracetamol 500 mg/stick pack - paracetamol - paracetamol - relief of pain and fever of different etiologies such as headache, toothache, cold, influenza, rheumatic pain and dysmenorrhea

AVCAMOL 250 MG Израел - английски - Ministry of Health

avcamol 250 mg

abic marketing ltd, israel - paracetamol - granules - paracetamol 250 mg/stick pack - paracetamol - analgesic, antipyretic .

EMTRICITABINETENOFOVIR TEVA Израел - английски - Ministry of Health

emtricitabinetenofovir teva

abic marketing ltd, israel - emtricitabine; tenofovir disoproxil as phosphate - film coated tablets - tenofovir disoproxil as phosphate 245 mg; emtricitabine 200 mg - tenofovir disoproxil and emtricitabine - treatment of hiv-1 infection: emtricitabine/tenofovir teva® is indicated in combination with other anti-retroviral medicinal products for the treatment of hiv-1 infected adults over 18 years of age.pre-exposure prophylaxis (prep): emtricitabine/tenofovir teva® is indicated in combination with safer sex practices for pre-exposure prophylaxis to reduce the risk of sexually acquired hiv-1 infection in adults at high risk.

TERIPARATIDE TEVA Израел - английски - Ministry of Health

teriparatide teva

abic marketing ltd, israel - teriparatide as acetate - solution for injection - teriparatide as acetate 250 mcg/ml - teriparatide - treatment of postmenopausal women with osteoporosis at high risk for fracture:teriparatide teva is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. in postmenopausal women with osteoporosis, teriparatide teva increases bmd reduces the risk of vertebral and nonvertebral fractures . increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture :teriparatide teva is indicated to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy . treatment of men and women with glucocorticoid-induced osteoporosis at high risk for fracture:teriparatide teva is indicated for the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture, defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy

LERCANAPRIL TEVA 10 10 Израел - английски - Ministry of Health

lercanapril teva 10 10

abic marketing ltd, israel - enalapril maleate; lercanidipine hydrochloride - film coated tablets - lercanidipine hydrochloride 10 mg; enalapril maleate 10 mg - enalapril and lercanidipine - treatment of essential hypertension in patients whose blood pressure cannot be adequately controlled under lercanidipine monotherapy.